Secretory Immunoglobulin a (SigA) Testing in Saliva from End-Stage Patients with Chronic Kidney Disease Undergoing Dialysis Treatment and in Control Healthy Subjects

The purpose of the present study was to measure SIgA levels in saliva in control healthy patients and in patients with end-stage chronic kidney disease (CKD) undergoing dialysis treatment.

Guardado en:
Detalles Bibliográficos
Autores principales: Nenova-Nogalcheva A., Konstantinova D., Pechalova P.
Formato: article
Lenguaje:EN
Publicado: Sciendo 2020
Materias:
R
Acceso en línea:https://doaj.org/article/e9e0b938912c435ba72b7da9b127fcb7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!